Intelligence Platform
Patents
Browse 783 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7510715
Protozoan derived compositions and methods of use thereof
granted patentUS 7504109
Influenza hemagglutinin and neuraminidase variants
granted patentUS 7504096
Methods for in vitro fertilization
granted patentUS 7494980
Antimicrobial peptide and methods of use thereof
granted patentUS 7488808
Janus family kinases and identification of immune modulators
granted patentUS 7485709
Identification of a novel BHD gene
granted patentUS 7485306
Lutzomyia longipalpis polypeptides and methods of use
granted patentUS 7455994
Methods for producing Marburg virus proteins
granted patentUS 7432067
Methods of detection of MATER protein autoantibodies
granted patentUS 7432236
Vasostatin as marrow protectant
granted patentUS 7427598
Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides f
granted patentUS 7427590
Neurothrophic components of the ADNF I complex
granted patentUS 7427394
Biodegradable poly(Ξ²-amino esters) and uses thereof
granted patentUS 7425611
Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use
granted patentUS 7419957
Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic met
granted patentUS 7419683
Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic ve
granted patentUS 7416878
Immunogenic compositions including rough phenotype Brucella host strains and complementati
granted patentUS 7407935
Ricin toxin A-chain fragment for use as a vaccine
granted patentUS 7407664
Peptide vaccines against group A streptococci
granted patentUS 7407658
Vaccines for blocking transmission of plasmodium vivax
granted patentUS 7404961
Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family protei
granted patentUS 7402567
Treatment of disease by inducing cell apoptosis
granted patentUS 7378257
Bacterial superantigen vaccines
granted patentUS 7378097
Use of penetration enhancers and barrier disruption methods to enhance the immune response
granted